A
ADCT
Adc Therapeutics Sa
3.740
-0.020-0.53%After Hours: 3.730 -0.010 -0.27%19:26 04/10 EDT
OPEN/PREV CLOSE3.790/3.760
TODAY RANGE3.690-3.824
VOL644.14K
MARKET CAP475.15M
52 WEEK RANGE1.050-4.980
AVG VOL (3M)812.87K
% TURNOVER0.51%
TURNOVER--
P/E (TTM)-3.3321
% RANGE3.57%
EPS(TTM)-1.1224
P/E(FORWARD)-4.5890
P/B-2.5308
BVPS-1.4778
DIVIDEND--
P/S5.78
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP391.99M
SHARES OUTSTANDING127.04M
NEXT EARNINGS05/12-05/18
FREE FLOAT104.81M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·04/04 00:07
ADC Therapeutics Earnings Call: Trials, Cash And Risks
PR Newswire·04/01 20:05
ADC Therapeutics Announces New Employee Inducement Grant
TipRanks·03/23 10:10
ADC Therapeutics price target raised to $8 from $7 at H.C. Wainwright
TipRanks·03/18 11:36
ADC Therapeutics (ADCT) Gets a Buy from Guggenheim
TipRanks·03/12 01:45
RBC Capital Sticks to Their Buy Rating for ADC Therapeutics (ADCT)
TipRanks·03/11 11:06
Guggenheim Sticks to Their Buy Rating for ADC Therapeutics (ADCT)
Simply Wall St·03/10 22:20
ADC Therapeutics (ADCT) Loss Narrowing To US$0.04 EPS Challenges Bearish Profitability Narrative
TipRanks·03/10 21:15
ADC Therapeutics files to sell 9.83M common shares for holders
Seeking Alpha·03/10 14:00
ADC Therapeutics outlines $600M–$1B peak revenue target for ZYNLONTA as LOTIS-5 and LOTIS-7 advance
NASDAQ·03/10 12:35
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates
NASDAQ·03/10 12:24
ADC Therapeutics Posts Narrower Loss In Q4
Same Industry
Name/Symbol
Change%
Price